Cell No. : Cell Name TDC0011 : PDT-LUAD#119  update : 2025/06/12
Comment			Currently not ready. Tumor organoid.
Comment from the depositor			A patient derived lung cancer organoid harboring EML4-ALK v3.
Terms and conditions
Remarks
Order Form
			Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
	Basic information	Expected time	Upon a request we will start preparation. Contact us: cellkitaku.brc@riken.jp
		IPR	Kawasaki Medical School
		Depositor	FUKAZAWA, Takuya
		Originator	FUKAZAWA, Takuya
Reference information		Reference	2
		User's Publication	0

Top

Reference

22962  Iwai M, Yokota E, Ishida Y, Yukawa T, Naomoto Y, Monobe Y, Haisa M, Takigawa N, Fukazawa T, Yamatsuji T.   Establishment and characterization of novel high mucus-producing lung tumoroids derived from a patient with pulmonary solid adenocarcinoma  Hum Cell  2024  ;37(4):1194-1204  PubMed ID: 38632190   DOI: 10.1007/s13577-024-01060-3

22963  Yokota E, Iwai M, Ishida Y, Yukawa T, Matsubara M, Naomoto Y, Fujiwara H, Monobe Y, Haisa M, Takigawa N, Fukazawa T, Yamatsuji T.   Transforming tumoroids derived from ALK-positive pulmonary adenocarcinoma to squamous cell carcinoma in vivo  Hum Cell  2024  37(4):1132-1140  PubMed ID: 38829559   DOI: 10.1007/s13577-024-01085-8

Top

User's Publication